The Dilemma of Pulmonary Valve Replacement In Patients With Repaired Tetralogy of Fallot

Amir-Reza Hosseinpour(1) , Matthias Kirsch(2) , Maria-Helena Perez(3) , Stefano Di Bernardo(4)
(1) Service of Cardiac surgery, Lausanne University Hospital,
(2) Lausanne University Hospital,
(3) Service of Cardiac surgery, Lausanne University Hospital, Switzerland,
(4) Service of Cardiac surgery, Lausanne University Hospital, Switzerland

Abstract

: Patients with repaired tetralogy of Fallot often have pulmonary valvar regurgitation with variable degrees of right ventricular dilatation, which may lead to dysfunction of both ventricles. Therefore, some patients may need pulmonary valve replacement. This calls for adequate patient selection, and there are ventricular volumetric guidelines to aid this. However, pulmonary valve replacement has caused a dilemma because: 1- It often does not reverse right ventricular dilatation back to normal nor prevent arrhythmias. 2- It is argued that right ventricular dilatation occurs early after repair of tetralogy of Fallot but remains stable thereafter. 3- The patient’ prognosis is said to be affected mainly by the function of the left ventricle rather than that of the right ventricle.  4- Prosthetic valves on the right side of the heart are more prone to infection as compared to the left side since bacteria can reach them easily. All these concerns are examined in this Opinion Article. Overall, this dilemma is justified but usually not sufficiently elaborated and often gives the incorrect message that this procedure is of no benefit.  The reality is, however, that pulmonary valvar regurgitation is a harmful condition and deserves to be remedied on hemodynamic grounds. The dilemma arises because hemodynamic improvement after valve implantation may be partial, and many think that this is not enough to justify an intervention, especially with the added risk of endocarditis. However, if valve replacement is to be offered, this should be done in a timely fashion; waiting too long is associated with a worse outcome.

Keywords:
    Pulmonary Valve Insufficiency, Pulmonary Valve Regurgitation, Pulmonary Valve Replacement, Tetralogy of Fallot, Adults with Congenital Heart disease

Full text article

Generated from XML file

References

Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92(2):231-237. https://doi.org/10.1161/01.CIR.92.2.231 PMid:7600655

Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC guide-lines for the management of adults with congenital heart disease: A report of the American College of Car-diology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(12):1494-1563. https://doi.org/10.1016/j.jacc.2018.08.1028 PMid:30121240

Wald RM, Haber I, Wald R, Valente AM, Powell AJ, Geva T. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation. 2009;119(10):1370-1377. https://doi.org/10.1161/CIRCULATIONAHA.108.816546 PMid:19255342 PMCid

Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation. 2009;119(3):445-451. https://doi.org/10.1161/CIRCULATIONAHA.108.775221 PMid:19139389 PMCid

Geva T, Gauvreau K, Powell AJ, Cecchin F, Rhodes J, Geva J, et al. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010;122(11 Suppl). https://doi.org/10.1161/CIRCULATIONAHA.110.951178 PMid:20837914 PMCid

Scherptong RW, Hazekamp MG, Mulder BJ, Wijers O, Swenne CA, van der Wall, et al. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and out-come. J Am Coll Cardiol. 2010;56(18):1486-1492. https://doi.org/10.1016/j.jacc.2020.04.058 PMid:32527397

Plymen CM, Finlay M, Tsang V, O'Leary J, Picaut N, Cullen S, et al. Haemodynamic consequences of targeted single- and dual-site right ventricular pacing in adults with congenital heart disease undergoing sur-gical pulmonary valve replacement. Europace. 2015;17(2):274-280. https://doi.org/10.1093/europace/euu281 PMid:25371427 PMCid

Bokma JP, Geva T, Sleeper LA, Babu Narayan SV, Wald R, Hickey K, et al. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2018;104(9):738-744. https://doi.org/10.1136/heartjnl-2017-312048 PMid:29092913

Cohen MI, Khairy P, Zeppenfeld K, Van Hare GF, Lakkireddy DR, Triedman JK. Preventing arrhythmic death in patients with tetralogy of Fallot: JACC review topic of the week. J Am Coll Cardiol. 2021;77(6):761-771.. https://doi.org/10.1016/j.jacc.2020.12.021 PMid:33573746

Van den Eynde J, Pompeu M, Vervoort D, Roever L, Meyns B, Budts W, et al. Pulmonary Valve Re-placement in Tetralogy of Fallot: An Updated Meta-Analysis. Ann Thorac Surg. 2022;113(3):1036-46.. https://doi.org/10.1016/j.athoracsur.2020.11.040 PMid:33378694

Hosseinpour AR, González-Calle A, Adsuar-Gómez A, Ho SY. The predicament of surgical correction of tetralogy of Fallot. Pediatr Cardiol. 2021;42(6):1252-1257. https://doi.org/10.1007/s00246-021-02662-6 PMid:34175987

Khairy P, Aboulhosn J, Gurvitz MZ, Opotowsky AR, Mongeon FP, Valente AM, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122(9):868-875. https://doi.org/10.1161/CIRCULATIONAHA.109.928481 PMid:20713900

Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, et al. Implantable cardiovert-er-defibrillators in tetralogy of Fallot. Circulation. 2008;117(3):363-370. https://doi.org/10.1161/CIRCULATIONAHA.107.726372 PMid:18172030

Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, et al. Sudden cardiac death in adult congenital heart disease. Circulation. 2012;126(16):1944-1954. https://doi.org/10.1161/CIRCULATIONAHA.112.104786 PMid:22991410

Gonzalez de Alba C, Khan A, Woods P, Broberg CS. Left ventricular strain and fibrosis in adults with repaired tetralogy of Fallot: A case-control study. Int J Cardiol. 2021;323:34-39. https://doi.org/10.1016/j.ijcard.2020.08.092 PMid:32882293

Diller G-P, Kempny A, Liodakis E, Alonso-Gonzalez R, Inuzuka R, Uebing A, et al. Left Ventricular Lon-gitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Te-tralogy of Fallot. Circulation. 2012;125(20):2440-2446. https://doi.org/10.1161/CIRCULATIONAHA.111.086983 PMid:22496160

Ait Ali L, Trocchio G, Crepaz R, Stuefer J, Stagnaro N, Siciliano V, et al. Left ventricular dysfunction in repaired tetralogy of Fallot: incidence and impact on atrial arrhythmias at long term follow up. Int J Cardi-ovasc Imaging. 2016;32(9):1441-1449. https://doi.org/10.1007/s10554-016-0928-7 PMid:27318953

Miyake M, Abe R, Matsutani H, Sakamoto J, Kondo H, Iwakura A, et al. Relationship between right and left ventricular diastolic dysfunction assessed by 2-dimensional speckle-tracking echocardiography in adults with repaired tetralogy of Fallot. Int J Cardiovasc Imaging. 2021;37(2):569-576. https://doi.org/10.1007/s10554-020-02045-7 PMid:33006716 PMCid

Andrade AC, Jerosch-Herold M, Wegner P, Gabbert DD, Voges I, Pham M, et al. Determinants of Left Ventricular Dysfunction and Remodeling in Patients With Corrected Tetralogy of Fallot. J Am Heart Assoc. 2019;8(17). https://doi.org/10.1161/JAHA.118.009618 PMid:31474177 PMCid

Egbe AC, Adigun R, Anand V, West CP, Montori VM, Murad HM, et al. Left Ventricular Systolic Dys-function and Cardiovascular Outcomes in Tetralogy of Fallot: Systematic Review and Meta-analysis. Can J Cardiol. 2019;35(12):1784-1790. https://doi.org/10.1016/j.cjca.2019.07.634 PMid:31732195

Wald R, Oechslin EN. Looking to the left to get it right: left ventricular systolic dysfunction and risk strati-fication late after tetralogy of Fallot repair. Can J Cardiol. 2019;35(12):1623-1625. https://doi.org/10.1016/j.cjca.2019.10.003 PMid:31813498

Hickey EJ, Veldtman G, Bradley TJ, Gengsakul A, Manlhiot C, Williams WG, et al. Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. Eur J Cardio-thorac Surg. 2009;35(1):156-164. https://doi.org/10.1016/j.ejcts.2008.06.050 PMid:18848456

Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating patho-physiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011;13(1):9. https://doi.org/10.1186/1532-429X-13-9 PMid:21251297 PMCid

Tobler D, Crean AM, Redington AN, Van Arsdell GS, Caldarone CA, Nanthakumar K, et al. The left heart after pulmonary valve replacement in adults after tetralogy of Fallot repair. Int J Cardiol. 2012;160(3):165-170. https://doi.org/10.1016/j.ijcard.2011.04.007 PMid:21570135

Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, Gatzoulis MA, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in The Indicator cohort. Heart. 2014;100(3):247-253. https://doi.org/10.1136/heartjnl-2013-304958 PMid:24179163 PMCid

Dragulescu A, Friedberg MK, Groose-Wortmann L, Redington A, Mertens L. Effect of chronic right ven-tricular volume overload on ventricular interaction in patients after tetralogy of Fallot repair. J Am Soc Echocardiogr. 2014;27(8):896-902. https://doi.org/10.1016/j.echo.2014.04.012 PMid:24846007

Orwat S, Diller G-P, Kempny A, Radke R, Peters B, Külne T, et al. Myocardial deformation parameters predict outcomes in patients with repaired tetralogy of Fallot. Heart. 2016;102(3):209-215. https://doi.org/10.1136/heartjnl-2015-308569 PMid:26715570

Pastor TA, Geva T, Lu M, et al. Relation of right ventricular dilation after pulmonary valve replacement to outcomes in patients with repaired tetralogy of Fallot. Am J Cardiol. 2020;125(6):977-981. https://doi.org/10.1016/j.amjcard.2019.12.017 PMid:31959431

Possner P, Tseng SY, Alahdab F, Bokma JP, Lubert AM, Khairy P, et al. Risk factors for mortality and ventricular tachycardia in patients with repaired tetralogy of Fallot: A systematic review and meta-analysis. Can J Cardiol. 2020;36(11):1815-1825. https://doi.org/10.1016/j.cjca.2020.01.023 PMid:32416063

Blais S, Marelli A, Vanasse A, et al. The 30-year outcomes of tetralogy of Fallot according to native anat-omy and genetic conditions. Can J Cardiol. 2021;37(6):877-886. https://doi.org/10.1016/j.cjca.2020.10.002 PMid:33059007

Buechel ERV, Dave HH, Kellenberger CJ, Dodge-Khatami A, Pretre R, Berger F, Bauersfeld U. Remodel-ling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fal-lot: assessment by cardiovascular magnetic resonance. Eur Heart J. 2005;26(24):2721-2727. https://doi.org/10.1093/eurheartj/ehi581 PMid:16214832

Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95(6):779-782. https://doi.org/10.1016/j.amjcard.2004.11.037 PMid:15757612

Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk APJ, Spijkerboer AM, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascu-lar magnetic resonance. Circulation. 2007;116(5):545-551. https://doi.org/10.1161/CIRCULATIONAHA.106.659664 PMid:17620511

Quail MA, Frigiola A, Giardini A, Muthurangu V, Hughes M, Lurz P, et al. Impact of pulmonary valve replacement in tetralogy of Fallot with pulmonary regurgitation: a comparison of intervention and noninter-vention. Ann Thorac Surg. 2012;94(5):1619-1626. https://doi.org/10.1016/j.athoracsur.2012.06.062 PMid:22959579

Ferraz Cavalcanti PE, Barros Oliveira Sá MP, Andrade Santos C, Melo Esmeraldo I, Renda de Escobar R, Motta de Menezes A, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol. 2013;62(23):2227-2243. https://doi.org/10.1016/j.jacc.2013.04.107 PMid:24080109

Hallbergson A, Gauvreau K, Powell AJ, Geva T. Right ventricular remodeling after pulmonary valve re-placement: early gains, late losses. Ann Thorac Surg. 2015;99(2):660-666. https://doi.org/10.1016/j.athoracsur.2014.09.015 PMid:25483002

Heng EL, Gatzoulis MA, Uebing A, Sethia B, Uemuera H, Smith GC, et al. Immediate and midterm cardi-ac remodelling after surgical pulmonary valve replacement in adults with repaired tetralogy of Fallot: a pro-spective cardiovascular magnetic resonance and clinical study. Circulation. 2017;136(18):1703-1713. https://doi.org/10.1161/CIRCULATIONAHA.117.027402 PMid:29084778 PMCid

Mongeon FP, Ben Ali W, Khairy P, Bouhout I, Therrien J, Wald RM, et al. Pulmonary valve replacement for pulmonary regurgitation in adults with tetralogy of Fallot: a meta-analysis - A report for the writing committee of the 2019 update of the Canadian Cardiovascular Society Guidelines for the management of adults with congenital heart disease. Can J Cardiol. 2019;35(12):1772-1783. https://doi.org/10.1016/j.cjca.2019.08.031 PMid:31813508

Lee C, Choi ES, Lee CH. Long-term outcomes of pulmonary valve replacement in patients with repaired tetralogy of Fallot. Eur J Cardiothorac Surg. 2020;58(2):246-252. https://doi.org/10.1093/ejcts/ezaa030 PMid:32047919

Rutz T, Ghandour F, Meierhofer C, Naumann S, Martinoff S, Lange R, et al. Evolution of right ventricular size over time after tetralogy of Fallot repair: a longitudinal cardiac magnetic resonance study. Eur Heart J Cardiovasc Imaging. 2017;18(3):364-370. https://doi.org/10.1093/ehjci/jew273 PMid:28363200

Luijnenburg SE, Helbing WA, Moelker A, Kroft LJM, Groenink M, Roos-Hesselink JW, et al. 5-year serial follow-up of clinical condition and ventricular function in patients after repair of tetralogy of Fallot. Int J Cardiol. 2013;169(6):439-444. https://doi.org/10.1016/j.ijcard.2013.10.013 PMid:24182670

Wald RM, Valente AM, Gauvreau K, Babu-Narayan SV, Assenza GE, Schreier J, et al. Cardiac magnetic resonance markers of progressive RV dilation and dysfunction after tetralogy of Fallot repair. Heart. 2015;101(21):1724-1730. https://doi.org/10.1136/heartjnl-2015-308014 PMid:26276804

Hoelscher M, Bonassin F, Oxenius A, Seifert B, Leonardi B, Kellenberger CJ, et al. Right ventricular dila-tation in patients with pulmonary regurgitation after repair of tetralogy of Fallot: How fast does it progress? Ann Pediatr Cardiol. 2020;13(4):294-300. https://doi.org/10.4103/apc.APC_140_19 PMid:33311917 PMCid

Balasubramanian S, Harrild DM, Kerur B, Marcus E, Del Nido P, Geva T, et al. Impact of surgical pulmo-nary valve replacement on ventricular strain and synchrony in patients with repaired tetralogy of Fallot: a cardiovascular magnetic resonance feature tracking study. J Cardiovasc Magn Reson. 2018;20(1):37. https://doi.org/10.1186/s12968-018-0460-0 PMid:29909772 PMCid

Geva T, Mulder B, Gauvreau K, Babu-Narayan SV, Wald RM, Hickey K, et al. Preoperative predictors of death and sustained ventricular tachycardia after pulmonary valve replacement in patients with repaired te-tralogy of Fallot enrolled in the INDICATOR cohort. Circulation. 2018;138(19):2106-2115. https://doi.org/10.1161/CIRCULATIONAHA.118.034740 PMid:30030416

Dorobantu DM, Sharabiani MTA, Taliotis D, Parry AJ, Tulloh RMR, Bentham JR, et al. Age over 35 years is associated with increased mortality after pulmonary valve replacement in repaired tetralogy of Fal-lot: results from the UK National Congenital Heart Disease Audit database. Eur J Cardiothorac Surg. 2020;58(4):825-831. https://doi.org/10.1093/ejcts/ezaa069 PMid:32187367 PMCid

Rozzi G, Lo Muzio FP, Fassina L, Rossi S, Statello R, Sandrini C, et al. Right ventricular functional recovery depends on the timing of pulmonary valve replacement in tetralogy of Fallot: a video kinematic study. Eur J Cardiothorac Surg. 2021;59(6):1329-1336. https://doi.org/10.1093/ejcts/ezab026 PMid:33547473

Dardari M, Cinteza E, Vasile CM, Padovani P, Vatasescu R. Infective endocarditis among pediatric patients with prosthetic valves and cardiac devices: A review and update of recent emerging diagnostic and manage-ment strategies. J Clin Med. 2023;12(15):4941. https://doi.org/10.3390/jcm12154941 PMid:37568344 PMCid

Demir F, Varan C, Erdem S, Atmis A, Akbas T, Subasi B, et al. Infective endocarditis in childhood: a single-centre experience of 26 years. Cardiol Young. 2023;33(10):1950-1955. https://doi.org/10.1017/S1047951122003419 PMid:36419327

Authors

Amir-Reza Hosseinpour
reza@hosseinpour.net (Primary Contact)
Matthias Kirsch
Maria-Helena Perez
Stefano Di Bernardo
Author Biographies

Amir-Reza Hosseinpour, Service of Cardiac surgery, Lausanne University Hospital

Professor Amir-Reza Hosseinpour is a British (of Iranian roots) congenital cardiac surgeon. He did all his studies and speciality training in the United Kingdom before moving to Seville in southern Spain in September 2006 to take up the position of Chief of Congenital Cardiac Surgery at the Virgen del Rocio University Hospital. He moved to Lausanne, Switzerland, in August 2022 to take up the same position at the Lausanne University Hospital. He is also an Associate Professor of Cardiac Surgery at the University of Lausanne.

Matthias Kirsch, Lausanne University Hospital

Professor Matthias Kirsch is a German cardiac surgeon. He did all his studies and speciality training in France (Paris) except for a fellowship that he did in Brussels. After having worked several years in Paris, he moved to Lausanne in September 2015 where he became the Chief of the Cardiac Surgery Service at the Lausanne University Hospital. He is also the Professor of Cardiac Surgery at the University of Lausanne.

Maria-Helena Perez, Service of Cardiac surgery, Lausanne University Hospital, Switzerland

Doctor Maria-Helena Perez is a Swiss (of Spanish roots) pediatric intensive care specialist. She did her studies and specialization in Lausanne and became a member of the pediatric ICU staff of the Lausanne University Hospital after her training. In 2018, she became the chief of that unit.

Stefano Di Bernardo, Service of Cardiac surgery, Lausanne University Hospital, Switzerland

Doctor Stefano Di Bernardo is a Swiss (of Italian roots) pediatric interventional cardiologist. He did his studies in Lausanne and his specialization in both Lausanne and Zurich. He joined the pediatric cardiology unit of the Lausanne University Hospital after his training. He is the deputy chief of that unit and is the coordinator of the interventional cardiology section.

Hosseinpour, A.-R., Kirsch, M., Perez, M.-H., & Di Bernardo, S. (2024). The Dilemma of Pulmonary Valve Replacement In Patients With Repaired Tetralogy of Fallot. Journal of Heart Valve Disease Innovation, 29(1), 30-36. https://doi.org/10.36923/jhvd.v29i1.212

Article Details

How to Cite

Hosseinpour, A.-R., Kirsch, M., Perez, M.-H., & Di Bernardo, S. (2024). The Dilemma of Pulmonary Valve Replacement In Patients With Repaired Tetralogy of Fallot. Journal of Heart Valve Disease Innovation, 29(1), 30-36. https://doi.org/10.36923/jhvd.v29i1.212

Similar Articles

You may also start an advanced similarity search for this article.